Cargando…
Metformin Treatment Suppresses Melanoma Cell Growth and Motility through Modulation of microRNA Expression
Melanoma is a highly aggressive cancer with high mortality in advanced stages. Metformin is an oral biguanide drug used for diabetes and has demonstrated positive effects on cancer prevention and treatment. Herein, we found that metformin significantly suppressed melanoma cancer cell motility and gr...
Autores principales: | Tseng, Hui-Wen, Li, Sung-Chou, Tsai, Kuo-Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406940/ https://www.ncbi.nlm.nih.gov/pubmed/30754729 http://dx.doi.org/10.3390/cancers11020209 |
Ejemplares similares
-
microRNA-324 plays an oncogenic role in bladder cancer cell growth and motility
por: Tsai, Kuo-Wang, et al.
Publicado: (2020) -
Involvement of MicroRNA-1-FAM83A Axis Dysfunction in the Growth and Motility of Lung Cancer Cells
por: Liu, Pei-Jung, et al.
Publicado: (2020) -
Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs
por: Fujita, Koji, et al.
Publicado: (2016) -
Metformin promotes histone deacetylation of optineurin and suppresses tumour growth through autophagy inhibition in ocular melanoma
por: Zhuang, Ai, et al.
Publicado: (2022) -
Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition
por: Kao, Hsiao-Wei, et al.
Publicado: (2023)